CRBU
Price
$1.79
Change
-$0.02 (-1.10%)
Updated
Dec 20, 04:59 PM (EDT)
92 days until earnings call
FATE
Price
$1.68
Change
+$0.02 (+1.20%)
Updated
Dec 20 closing price
70 days until earnings call
Ad is loading...

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$1.79
Change-$0.02 (-1.10%)
Volume$12.57K
CapitalizationN/A
Fate Therapeutics
Price$1.68
Change+$0.02 (+1.20%)
Volume$10.14M
CapitalizationN/A
CRBU vs FATE Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FATE commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FATE is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (CRBU: $1.80 vs. FATE: $1.68)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 129% vs. FATE: 307%
Market capitalization -- CRBU: $162.54M vs. FATE: $192.48M
CRBU [@Biotechnology] is valued at $162.54M. FATE’s [@Biotechnology] market capitalization is $192.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 2 TA indicator(s) are bullish while FATE’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 2 bullish, 7 bearish.
  • FATE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FATE is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -5.76% price change this week, while FATE (@Biotechnology) price change was -8.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CRBU is expected to report earnings on Mar 24, 2025.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($192M) has a higher market cap than CRBU($163M). FATE YTD gains are higher at: -55.080 vs. CRBU (-68.586). CRBU has higher annual earnings (EBITDA): -161.7M vs. FATE (-177.57M). FATE has more cash in the bank: 297M vs. CRBU (228M). CRBU has less debt than FATE: CRBU (26.6M) vs FATE (99M). FATE has higher revenues than CRBU: FATE (13.4M) vs CRBU (11.5M).
CRBUFATECRBU / FATE
Capitalization163M192M85%
EBITDA-161.7M-177.57M91%
Gain YTD-68.586-55.080125%
P/E RatioN/AN/A-
Revenue11.5M13.4M86%
Total Cash228M297M77%
Total Debt26.6M99M27%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 14 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBMYX29.720.46
+1.57%
BNY Mellon Sm/Md Cp Gr Y
FHCCX46.040.55
+1.21%
Fidelity Advisor Health Care C
PDAVX11.750.10
+0.86%
PineBridge Dynamic Asset Allc Invt Svcng
ODMCX11.040.07
+0.64%
JPMorgan SMID Cap Equity C
GQSCX14.130.04
+0.28%
Glenmede Quant US Small Cap Equity

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with ALLO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-0.55%
ALLO - CRBU
56%
Loosely correlated
+1.63%
BEAM - CRBU
52%
Loosely correlated
+8.04%
ARVN - CRBU
51%
Loosely correlated
+3.65%
FATE - CRBU
51%
Loosely correlated
+1.20%
AXON - CRBU
50%
Loosely correlated
+2.60%
More